Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effect on the body of combining oxaliplatin with bortezomib in
treating patients who have metastatic or unresectable cancer. Drugs used in chemotherapy such
as oxaliplatin use different ways to stop cancer cells from dividing so they stop growing or
die. Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for
tumor cell growth. Combining oxaliplatin with bortezomib may kill more cancer cells